Prescription-Grade Medical Standard
This product is manufactured under strict pharmaceutical-grade quality control processes. Batch-specific Certificates of Analysis (COA) are available in accordance with the requirements of ANVISA (Brazilian Health Regulatory Agency).
The raw materials are produced in cGMP-certified facilities, following standardized cannabinoid profiling and formulation stability processes.
This high-concentration CBD tincture is fully aligned with the RDC 660/2022 regulatory framework, supporting medical prescription and legal personal importation, with complete traceability and compliance documentation.
Quality & Safety Documentation
Comprehensive Compliance Documentation
Each batch is accompanied by independent third-party laboratory reports, including:
Quantitative cannabinoid potency analysis
The formulation strictly complies with Brazilian and international THC limits, contains no artificial chemical additives, and is supported by complete production records, COAs, and legal documentation required for importation.
This documentation fully supports clinical evaluation by physicians and patient submission to ANVISA for import authorization.
Manufacturing & Compliance
Global Pharmaceutical Production Standards
Jayrwell CBD raw materials are produced in cGMP-certified facilities in China, utilizing a quality-controlled supercritical CO₂ extraction process, ensuring high purity, potency consistency, and batch-to-batch reproducibility.
The finished tincture is manufactured in European facilities, ensuring controlled and reliable quality.
A complete documentation package tailored to RDC 660/2022 is provided to facilitate prescription review and the ANVISA-approved personal importation process (Importação para Uso Pessoal).
Manufacturing Background:
Raw materials and formulations originate from a publicly listed pharmaceutical company in China, with over 90% of its production capacity supplying medicines listed in China’s national reimbursement system and more than 90% of hospitals nationwide, reflecting deep pharmaceutical expertise and a robust quality assurance system.
Potential Health Benefits
Based on existing clinical research, natural CBD extracts may provide supportive benefits in the following areas:
Daily Well-being — Supports mind-body balance and helps maintain focus and vitality
Mood Regulation — May contribute to mental clarity and a sense of calm
Physical Recovery — May assist in post-exercise inflammatory response and muscle discomfort
Sleep Quality — May help maintain healthy sleep cycles
FQA
1. What is Full Spectrum CBD?
Full spectrum CBD preserves the complete profile of naturally occurring cannabinoids, terpenes, and beneficial compounds found in the hemp plant, including trace amounts of THC (<0.2%).
These components may work synergistically through the “entourage effect,” potentially enhancing the overall support of the formulation. Jayrwell strictly complies with ANVISA’s THC limits.
2. What is the difference between Full Spectrum and Broad Spectrum?
Full Spectrum: Contains all naturally occurring cannabinoids, including trace THC (<0.2%)
Broad Spectrum: Contains multiple cannabinoids, but THC is completely removed
Studies suggest that full spectrum formulations retaining trace THC may offer enhanced support due to the entourage effect.
3. Why choose Jayrwell CBD Tinctures?
✅ European cGMP pharmaceutical-grade manufacturing
✅ Fully aligned with Brazil’s RDC 660/2022 regulatory framework
✅ Batch-specific COAs and independent third-party laboratory testing
✅ Three concentrations tailored to different clinical needs
✅ Backed by a publicly listed pharmaceutical group in China, ensuring traceability
✅ Complete documentation designed for Brazilian prescriptions and patient importation
4. Effects of Using Jayrwell CBD Tinctures
Effects may vary depending on individual metabolism, dosage, and health condition. Many users report noticeable benefits after 2–4 weeks of consistent use, such as:
Improved daily stress management
Better sleep quality
Enhanced post-exercise recovery
Use should always be guided by a qualified healthcare professional.
5. Why Manufactured in Europe?
Europe maintains one of the world’s most stringent regulatory systems for cannabinoid production, comparable to EU GMP standards. Manufacturing in Europe ensures:
Compliance with international pharmaceutical-grade requirements
Successful EU-level quality audits
Alignment with ANVISA’s high standards for imported medical products
This reflects our commitment to patient safety, regulatory compliance, and product quality.

Customer Reviews